LENSAR (NASDAQ:LNSR) Trading 5.8% Higher

LENSAR, Inc. (NASDAQ:LNSR)’s stock price traded up 5.8% during mid-day trading on Wednesday . The stock traded as high as $4.39 and last traded at $4.39. 19,925 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 36,602 shares. The stock had previously closed at $4.15.

Wall Street Analyst Weigh In

Separately, Lake Street Capital assumed coverage on shares of LENSAR in a research report on Tuesday, March 19th. They issued a “buy” rating and a $8.00 price objective for the company.

LENSAR Stock Performance

The company has a 50 day moving average price of $4.03 and a 200 day moving average price of $3.85.

LENSAR (NASDAQ:LNSR) last released its earnings results on Thursday, May 9th. The company reported ($0.19) EPS for the quarter. The business had revenue of $10.59 million for the quarter. LENSAR had a negative net margin of 27.57% and a negative return on equity of 36.53%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in LENSAR stock. Brandes Investment Partners LP increased its stake in LENSAR, Inc. (NASDAQ:LNSR) by 3.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 226,676 shares of the company’s stock after purchasing an additional 6,827 shares during the quarter. Brandes Investment Partners LP owned approximately 2.01% of LENSAR worth $796,000 as of its most recent filing with the Securities and Exchange Commission. 40.15% of the stock is currently owned by institutional investors and hedge funds.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.